184 related articles for article (PubMed ID: 23560914)
1. Utilizing Salmonella for antigen delivery: the aims and benefits of bacterial delivered vaccination.
Kong W; Clark-Curtiss J; Curtiss R
Expert Rev Vaccines; 2013 Apr; 12(4):345-7. PubMed ID: 23560914
[No Abstract] [Full Text] [Related]
2. Salmonella enterica as a vaccine carrier.
Hegazy WA; Hensel M
Future Microbiol; 2012 Jan; 7(1):111-27. PubMed ID: 22191450
[TBL] [Abstract][Full Text] [Related]
3. Delivery of antigens used for vaccination: recent advances and challenges.
Scherliess R
Ther Deliv; 2011 Oct; 2(10):1351-68. PubMed ID: 22826888
[TBL] [Abstract][Full Text] [Related]
4. Enteric pathogens as vaccine vectors for foreign antigen delivery.
Kotton CN; Hohmann EL
Infect Immun; 2004 Oct; 72(10):5535-47. PubMed ID: 15385450
[No Abstract] [Full Text] [Related]
5. Animal vaccines based on orally presented yeast recombinants.
Shin MK; Yoo HS
Vaccine; 2013 Sep; 31(40):4287-92. PubMed ID: 23891501
[TBL] [Abstract][Full Text] [Related]
6. A bacterium's guide to orienteering in the intestinal lumen. Interview by Emma Louise Walton.
Jang YS
Microbes Infect; 2013 Nov; 15(13):845-8. PubMed ID: 24140556
[No Abstract] [Full Text] [Related]
7. Rational design of Salmonella-based vaccination strategies.
Spreng S; Dietrich G; Weidinger G
Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
[TBL] [Abstract][Full Text] [Related]
8. Gut-associated lymphoid tissues for the development of oral vaccines.
Kunisawa J; Kurashima Y; Kiyono H
Adv Drug Deliv Rev; 2012 May; 64(6):523-30. PubMed ID: 21827802
[TBL] [Abstract][Full Text] [Related]
9. Vaccination markers: designing unique antigens to be added to vaccines to differentiate between natural infection and vaccination.
Root-Bernstein RS
Vaccine; 2005 Mar; 23(17-18):2057-9. PubMed ID: 15755570
[TBL] [Abstract][Full Text] [Related]
10. Nanocarriers: a versatile approach for mucosal vaccine delivery.
Mody N; Sharma R; Agrawal U; Vyas SP
Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
[TBL] [Abstract][Full Text] [Related]
11. Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines.
Zhang L; Zeng Z; Hu C; Bellis SL; Yang W; Su Y; Zhang X; Wu Y
Biomaterials; 2016 Jan; 77():307-19. PubMed ID: 26624805
[TBL] [Abstract][Full Text] [Related]
12. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
[TBL] [Abstract][Full Text] [Related]
13. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
Dietrich G; Spreng S; Gentschev I; Goebel W
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.
Babiuk S; Baca-Estrada M; Babiuk LA; Ewen C; Foldvari M
J Control Release; 2000 May; 66(2-3):199-214. PubMed ID: 10742580
[TBL] [Abstract][Full Text] [Related]
15. Delivery strategies to enhance oral vaccination against enteric infections.
Davitt CJ; Lavelle EC
Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
[TBL] [Abstract][Full Text] [Related]
17. β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination.
De Smet R; Demoor T; Verschuere S; Dullaers M; Ostroff GR; Leclercq G; Allais L; Pilette C; Dierendonck M; De Geest BG; Cuvelier CA
J Control Release; 2013 Dec; 172(3):671-8. PubMed ID: 24041710
[TBL] [Abstract][Full Text] [Related]
18. [Oral vaccination and vaccine-entrapped microparticle delivery system].
Li FQ; Fei YB; Su H; Hu JH
Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
[TBL] [Abstract][Full Text] [Related]
19. Nasal vaccine innovation.
Jabbal-Gill I
J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
[TBL] [Abstract][Full Text] [Related]
20. Oral vaccination using recombinant bacteria.
Schödel F
Semin Immunol; 1990 Sep; 2(5):341-9. PubMed ID: 2134017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
